Twist raises $61M in series D

Twist Bioscience Corp. (San Francisco, Calif.) raised $61 million in a series D round. New investors WuXi Healthcare Ventures, Arch Overage Fund, Merieux Developpement, Cormorant Asset Management and Boris Nikolic joined existing investors Arch Venture Partners, Fidelity, Illumina Inc. (NASDAQ:ILMN), Tao Invest, Foresite Capital, Yuri Milner and Paladin Capital, along with undisclosed other strategic and venture investors, in the round. ...